Role of human natural killer cells in health and disease

T L Whiteside, R B Herberman, T L Whiteside, R B Herberman

Abstract

Natural killer (NK) cells, the CD3- CD56+ CD16+ subset of peripheral blood lymphocytes, have long been known to be involved in non-major histocompatibility complex-restricted natural immunity to virally infected and malignant target cells. The association of abnormalities in NK cell numbers or functions with a broad spectrum of human diseases has been more clearly defined in recent years as a result of the improved knowledge of NK cell physiology and advances in monitoring of NK cell functions in health and disease. The ability to reliably measure changes in NK activity and/or numbers during the course of disease or response to treatment has focused attention on the role of the NK cell in disease pathogenesis. The improved understanding of NK cell deficiency in disease has opened a way for therapies specifically designed to improve NK cell function. The therapeutic use of biologic response modifiers capable of augmenting NK cell activity in vivo and of adoptive transfer of highly enriched, activated autologous NK cells in diseases such as cancer and AIDS is being evaluated. The importance of NK cells in health and the consequences of NK cell deficiency or excess are likely to be more extensively monitored in the future.

References

    1. J Exp Med. 1990 May 1;171(5):1509-26
    1. J Exp Med. 1986 Jan 1;163(1):209-14
    1. J Clin Immunol. 1986 Jan;6(1):1-8
    1. J Immunol. 1986 Jun 15;136(12):4480-6
    1. J Exp Med. 1986 Oct 1;164(4):1193-205
    1. Nat Immun Cell Growth Regul. 1986;5(4):169-99
    1. N Engl J Med. 1987 Apr 9;316(15):889-97
    1. J Immunol. 1987 Jul 1;139(1):279-84
    1. Diagn Clin Immunol. 1987;5(2):69-81
    1. J Immunol. 1987 Oct 15;139(8):2761-7
    1. Gastroenterology. 1988 Nov;95(5):1318-25
    1. Brain Behav Immun. 1988 Mar;2(1):1-10
    1. J Exp Med. 1989 Feb 1;169(2):549-67
    1. J Exp Med. 1989 Feb 1;169(2):569-83
    1. N Engl J Med. 1989 Jun 29;320(26):1731-5
    1. Immunol Today. 1988 Oct;9(10):291-3
    1. J Immunol. 1993 Mar 1;150(5):1705-14
    1. Cell Immunol. 1993 Apr 1;147(2):397-410
    1. Cell. 1993 Apr 9;73(1):5-8
    1. J Immunol. 1993 Jun 1;150(11):4844-55
    1. J Exp Med. 1993 Aug 1;178(2):597-604
    1. J Immunol. 1993 Aug 15;151(4):1926-37
    1. J Exp Med. 1990 May 1;171(5):1527-33
    1. Br J Haematol. 1990 May;75(1):49-59
    1. Clin Immunol Immunopathol. 1990 Sep;56(3):401-19
    1. J Immunol. 1990 Nov 15;145(10):3194-201
    1. J Immunol. 1991 Jan 1;146(1):384-92
    1. Blood. 1990 Dec 15;76(12):2421-38
    1. J Exp Med. 1991 Feb 1;173(2):439-48
    1. J Biol Response Mod. 1990 Dec;9(6):546-55
    1. Ann Ist Super Sanita. 1990;26(3-4):335-48
    1. Clin Immunol Immunopathol. 1991 Jun;59(3):355-67
    1. Curr Opin Immunol. 1991 Feb;3(1):49-55
    1. Cell Immunol. 1991 Jan;132(1):177-92
    1. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5989-92
    1. Hepatology. 1991 Sep;14(3):495-503
    1. Lab Invest. 1992 Feb;66(2):138-42
    1. Crit Rev Oncol Hematol. 1992 Jan;12(1):25-47
    1. Cell. 1992 Apr 3;69(1):11-25
    1. J Immunol. 1992 Jul 1;149(1):340-9
    1. J Exp Med. 1992 Aug 1;176(2):531-41
    1. Invasion Metastasis. 1992;12(2):128-46
    1. J Clin Invest. 1993 Jan;91(1):123-32
    1. Transplantation. 1993 Aug;56(2):409-17
    1. J Natl Cancer Inst. 1993 Sep 15;85(18):1475-82
    1. J Immunol. 1993 Sep 15;151(6):3018-29
    1. J Clin Immunol. 1993 Jul;13(4):237-46
    1. J Allergy Clin Immunol. 1993 Nov;92(5):732-43
    1. J Exp Med. 1977 May 1;145(5):1411-6
    1. Nature. 1979 Jan 18;277(5693):221-3
    1. Nature. 1981 May 28;291(5813):335-8
    1. J Clin Oncol. 1984 Apr;2(4):336-52
    1. J Exp Med. 1985 Jan 1;161(1):40-52
    1. Clin Immunol Immunopathol. 1989 Oct;53(1):1-23
    1. J Immunol. 1989 Oct 1;143(7):2415-21
    1. Nat Immun Cell Growth Regul. 1989;8(3):173-86
    1. Nature. 1989 Sep 14;341(6238):159-62
    1. Ann Surg. 1989 Oct;210(4):474-84; discussion 484-5
    1. J Immunol. 1989 Nov 15;143(10):3183-91
    1. Adv Immunol. 1989;47:187-376
    1. J Immunol. 1989 Dec 1;143(11):3853-7
    1. Cell Immunol. 1990 Jan;125(1):183-96
    1. J Clin Lab Anal. 1990;4(2):102-14
    1. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2274-8
    1. Cancer Res. 1990 May 1;50(9):2683-91

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner